期刊文献+

碘油-聚乳酸微球栓塞兔肾动脉的实验研究

Experimental research of rabbit renal artery embolism with lipiodol-polylactic acid microspheres
下载PDF
导出
摘要 目的通过兔肾动脉栓塞实验研究碘油-聚乳酸(LP-PLA)微球的X线可视性、栓塞效果及生物相容性。方法新西兰大白兔36只随机分为LP-PLA微球(LP-PLA)组和聚乙烯醇颗粒(PVA)组,栓塞后1、4、12周两组随机选取6只大白兔行肾动脉造影,后再对比双肾组织病理学差异,并明确栓塞前后相关指标的变化。结果透视下可观察到LPPLA微球的行程,栓塞术后1周栓塞材料仍显影;栓塞后1、4、12周造影两组均未见肾段动脉再通。两组栓塞后1周栓塞侧肾重量均较健侧肾显著增加(P<0.05),栓塞后4、12周栓塞侧肾均明显萎缩,健侧肾均代偿性增大,明显重于栓塞侧肾(P<0.05)。两组栓塞侧肾病理特点与血栓形成、机化相似;LP-PLA组栓塞动脉周围的异物巨细胞及炎症较PVA组明显。结论碘油-聚乳酸微球具有良好的X线可视性及组织相容性,并且其远期栓塞效果与PVA相似。 Objective To evaluate the radiopacity, embolic effect and biocompatibility of lipiodol polylactic acid (LP- PLA) microspheres in the setting of rabbit renal artery embolism. Methods Totally 36 healthy mature New Zealand white rabbits were randomly divided into two groups: LP-PLA group (left renal artery embolism by LP-PLA microspheres) and PVA group (left renal artery embolism by PVA particles). Six big white rabbits in each group were randomly selected to perform the radiography, and blood routine and biochemistry tests (including hepatic and renal function) were measured at 1, 4 and 12 weeks after embolism. Pathological features on the left and right kidney were compared. Results LP-PLA microspheres mixing with normal saline could pass the pipe smoothly and its track under fluoroscopy monitor could be observed 1 week after embolism. Renal arteries were hot recanalized by angiography in each group at 1, 4 and 12 weeks after embolism. In both groups, the weight of the embolic kidney were significantly increased, compared with that of the healthy kidney at 1 week after embolism (P〈0.05) ; the embolic kidneys obviously atrophied and the healthy kidneys showed compensatory hypertrophy at 4, 12 weeks after embolism (P〈0.05). The pathology of embolic kidneys showed thrombogenesis and organization, and the foreign body giant cells and inflammation reactions around the embolic artery in LP-PLA group were more obvious than those in PVA group. Conclusion LP-PLA microspheres demonstrate good radiopacity as well as histocompatibility in animal experiment, and it also shares similar long-time embolic effect with PVA.
出处 《中国介入影像与治疗学》 CSCD 北大核心 2015年第8期503-507,共5页 Chinese Journal of Interventional Imaging and Therapy
基金 新型末梢血管栓塞剂的研制及临床应用(2005B104010108)
关键词 碘油-聚乳酸微球 不透X线性 生物相容性 栓塞 治疗性 Lipiodol-polylactic acid microspheres Rabbits Radiopacity Biocompatible Embolization, therapeutic
  • 相关文献

参考文献10

  • 1赵锋,高永良.乳化分散法制备聚乳酸微球的研究进展[J].中国新药杂志,2002,11(2):123-126. 被引量:17
  • 2Oh JE, Nam YS, Lee KH, et al. Conjugation of drug to poly(D, L-laetie-co-glycolic acid) for controlled release from biodegradable microspheres. J Control Release, 1999,57(3) : 269-280.
  • 3曹婷颖,顾月清,高向东.聚乳酸载药微球的制备和给药方法[J].药学进展,2006,30(10):448-452. 被引量:14
  • 4中华人民共和国国家质量监督检验检疫总局.GB/T16175-2008医用有机硅材料生物学平价试验方法.北京:中国标准出版社出版,1996:17.
  • 5Kwak BK, Shim H J, Han SM, et al. Chitin-based embolic mate-rials in the renal artery of rabbits: pathologic evaluation of an ab- sorbable particulate agent. Radiology, 2005,236(1) : 151-158.
  • 6Oerlemans C, Seevinck PR, Smits ML, et al. Holmium-lipiodol- alginate microspheres for fluoroseopy-guided embolotherapy and multimodality imaging. Int J Pharm, 2015,482(1/2) :47-53.
  • 7Wang Q, Qian K, Liu S, et al. X-ray visible and uniform alginate microspheres loaded with in situ synthesized BaSO4 nanoparticles for in vivo transcatheter arterial embolization. Biomacromole- cules, 2015,16(4) : 1240-1246.
  • 8Stampfl U, Sommer CM, Bellemann N, et al. Multimodal visibil- ity of a modified polyzene-F-coated spherical embolic agent for liv- er embolization: feasibility study in a porcine model. J Vase In- terv Radiol, 2012,23(9) :1225-1231: e2.
  • 9Hyon SH. Biodegradable poly (lactic acid) microspheres for drug delivery systems. Yonsei Med J, 2000,41(6) : 720-734.
  • 10Yamamoto T, Hayakawa K, Tabata Y, et al. Transcatheter ar- terial embolization using poiy-L-lactic acid microspheres. Radiat Med, 2003,21(4) :150-154.

二级参考文献37

  • 1Okada H,Toguchi H.Biodegradable microspheres in drug delivery[J].Crit Rev Ther Drug Carrier Syst,1995,12(1):1-99.
  • 2Hyon S H.Biodegradable poly (lactic acid) microspheres for drug delivery systems[J].Yonsei Med J,2000,41(6):720-734.
  • 3Oh J E,Nam Y S,Lee K H,et al.Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres[J].J Controlled Release,1999,57(3):269-280.
  • 4McGinity J W,O' Donnell P B.Preparation of microspheres by the solvent evaporation technique[J].Adv Drug Deliv Rev,1997,28(1):25-42.
  • 5Chung T W,Huang Y Y,Liu Y Z.Effects of the rate of solvent evaporation on the characteristics of drug loaded PLLA and PDLLA microspheres[J].Int J Pharm,2001,212(2):161-169.
  • 6Jain R A.The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices[J].Biomaterials,2000,21(23):2475-2490.
  • 7Urata T,Arimori K,Nakano H.Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres[J].J Controlled Release,1999,58(2):133-141.
  • 8Gang R,Si S F.Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid)(PLA-PEG-PLA) microspheres for controlled release of paclitaxel[J].Biomaterials,2003,24(27):5037-5044.
  • 9Hussain M,Beale G,Hughes M,et al.Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer[J].Int J Pharm,2002,234(1-2):129-138.
  • 10Herrmann J,Bodmeier R.Biodegradable somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods[J].Eur J Pharm Biopharm,1998,45(1):75-82.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部